There were minor changes in number of overall intrahepatic leukocytes and expression of CXCR3 in myeloid population in FHL and CD8 T cells in MAS but this therapeutic intervention did not ameliorate liver injury. The gene discussed is CXCR3; the disease is macrophage activation syndrome.